Most statin drugs are FDA-approved for children and teens under age 18, but only if they have a genetic condition that cause extremely high levels of LDL (bad) cholesterol. Yet in 2009 ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin ... Crestor and several other blockbusters encountered generic competition. Income arising from the upfront ...

Since several medications may be in one category or class, each plan decides its own formulary of covered drugs. Some plans may offer more generic medications and lower premiums and copays ...

The US Food and Drug Administration has approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide (Victoza, Novo Nordisk) to lower ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

AstraZeneca has bought rights to an orally-active drug that inhibits PCSK9, offering a patient-friendly alternative to current cholesterol ... accustomed to low-cost generic statins.

This means that Ranbaxy can advance the launch of its generic version of the cholesterol-lowering drug in Australia by 4 months to May 2012 when the patent expires. Ranbaxy is currently fighting a ...

Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive.

Millions of people take statins like Simvastatin (above) to lower their cholesterol levels. Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart ...